medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2024, Número 5

<< Anterior Siguiente >>

Acta Pediatr Mex 2024; 45 (5)


Uso de módulos nutricionales en la práctica pediátrica actual

López ML, Núñez BI, Bautista SM, Silva MI, Vela AMB, Guillén LS

Idioma: Español
Referencias bibliográficas: 71
Paginas: 488-502
Archivo PDF: 260.85 Kb.


RESUMEN

Los módulos nutricionales son mezclas o aislados de macronutrimentos que pueden estar enriquecidas con micronutrimentos. Se añaden generalmente en pediatría a la fórmula o a preparados enterales para aumentar el aporte energético o de algún nutrimento específico. Existen módulos de hidratos de carbono entre los cuales se puede mencionar: maltodextrinas, cereales, almidón de maíz. En los módulos de proteína se considera la concentración, así como la adición de fortificadores y finalmente los módulos de lípidos están integrados por aceite vegetal, triglicéridos de cadena media y mezclas mixtas. La osmolaridad debe considerarse dependiendo el tipo de fórmula y módulo a utilizar, los módulos de hidratos de carbono por lo general son los que más aumentan la osmolaridad. La utilidad de la adición de módulos nutricionales en la pediatría actual persiste y resulta una herramienta beneficiosa en diversas patologías y estados nutricionales.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Pedrón-Giner C, Moreno-Villares JM, Dalmau-Serra J, etal. Fómulas de nutrición enteral en pediatría. An PediatrContin. 2011; 9(4):209-23.

  2. Secretaría de Salud (SSA). Norma Oficial Mexicana NOM-086-SSA1-1994, Bienes y servicios. Alimentos y bebidasno alcohólicas con modificaciones en su composición.Especificaciones nutrimentales. Ciudad de México: SSA.

  3. Davis A, Baker S. The use of modular nutrients in pediatrics.JPEN J Parenter Enteral Nutr. 1996; 20(3):228-36.Doi: 10.1177/0148607196020003228. Erratum in: JPEN JParenter Enteral Nutr .1996;20(4):305.

  4. Pereira-da-Silva L, Pitta-Grós M, Virella D, et al. Osmolalityof elemental and semi-elemental formulas supplementedwith nonprotein energy supplements. J HumNutr Diet. 2008; 21(6): 584–90. Doi: 10.1111/j.1365-277X.2008.00897.x.

  5. Moreno-Villares JM, Oliveros- Leal L, Galiano-SegoviaMJ. Cómo enriquecer la alimentación del lactante: usode los módulos nutricionales. Acta Pediatr Esp. 2003;

  6. 61(8): 406-12.6. Simone L. Enteral Nutrition. Chapter 19. En: Queen-SamourP, King K, editores. Pediatric Nutrition. 4a edición. Sudbury:Jones & Barlett Learning; 2012. p. 401.

  7. Steele JR, Meskell RJ, Foy J, et al. Determining the osmolalityof over-concentrated and supplemented infant formulas.J Hum Nutr Diet. 2013;26(1):32-7. Doi: 10.1111/j.1365-277X.2012.01286.x.

  8. Sociedad Española de Gastroenterología, Hepatología yNutrición Pediátrica. Tratamiento en Gastroenterología,Hepatología y Nutrición Pediátrica. 5ª edición. Madrid,España: Ergon; 2021.

  9. Bello-Pérez LA, Sánchez-Hernández L, Moreno-DamíanE, et al. Laboratory scale production of maltodextrinsand glucose syrup from banana starch. Acta Cient Venez.2002; 53 (1):44-8.

  10. Hofman DL, van Buul VJ, Brouns FJ. Nutrition, Health,and Regulatory Aspects of Digestible Maltodextrins.Crit Rev Food Sci Nutr. 2016; 56(12):2091-100. Doi:10.1080/10408398.2014.940415.

  11. Livesey G, Tagami H. Interventions to lower the glycemicresponse to carbohydrate foods with a low-viscosity fiber(resistant maltodextrin): meta-analysis of randomizedcontrolled trials. Am J Clin Nutr. 2009; 89: 114–25. Doi:10.3945/ajcn.2008.26842.

  12. Greer F, Sicherer S, Burks A, et al. Effects of Early NutritionalInterventions on the Development of Atopic Disease inInfants and Children: The Role of Maternal Dietary Restriction,Breastfeeding, Timing of Introduction of ComplementaryFoods, and Hydrolyzed Formulas. Pediatrics. 2008; 121(1):183-91. Doi: 10.1542/peds.2007-3022.

  13. Agostoni C, Brunser O. Issues in Complementary Feeding.Basel: S. Karger AG;2007.

  14. Chao HC, Vandenplas Y. Effect of cereal-thickened formulaand upright positioning on regurgitation, gastric emptying,and weight gain in infants with regurgitation. Nutrition.2007;23(1):23-8. Doi: 10.1016/j.nut.2006.10.003.

  15. Rosen R, Vandenplas Y, Singendonk M, et al. PediatricGastroesophageal Reflux Clinical Practice Guidelines:Joint Recommendations of the North American Societyfor Pediatric Gastroenterology, Hepatology, and Nutritionand the European Society for Pediatric Gastroenterology,Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr.2018;66(3):516-554.

  16. Fewtrell M, Bronsky J, Campoy C, et al. ComplementaryFeeding: A Position Paper by the European Society forPaediatric Gastroenterology, Hepatology, and Nutrition(ESPGHAN) Committee on Nutrition. J PediatrGastroenterol Nutr. 2017;64(1):119-32. Doi: 10.1097/MPG.0000000000001454.

  17. Klerks M, Bernal MJ, Roman S. Infant Cereals: CurrentStatus, Challenges, and Future Opportunities forWhole Grains. Nutrients. 2019;11(2):473. Doi: 10.3390/nu11020473.

  18. Yu JK, Moon YS. Corn Starch: Quality and Quantity Improvementfor Industrial Uses. Plants (Basel). 2021;11(1):92.Doi:10.3390/plants11010092.

  19. Derks TGJ, Rodriguez-Buritica DF, Ahmad A, et al. GlycogenStorage Disease Type Ia: Current Management Options,Burden and Unmet Needs. Nutrients. 2021;13(11):3828.Doi: 10.3390/nu13113828.

  20. Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis andmanagement of glycogen storage disease type I: a practiceguideline of the American College of Medical Genetics andGenomics. Genet Med. 2014;16(11):e1. Doi: 10.1038/gim.2014.128

  21. Della Pepa G, Vetrani C, Lupoli R, Massimino E, et al.Uncooked cornstarch for the prevention of hypoglycemicevents. Crit Rev Food Sci Nutr. 2022;62(12):3250-63. Doi:10.1080/10408398.2020.1864617.

  22. Murray, R.D. Savoring Sweet: Sugars in Infant and ToddlerFeeding. Ann Nutr Metab. 2017; 70: 38–46.

  23. Fidler Mis N, Braegger C, Bronsky J, et al. Sugar in Infants,Children and Adolescents: A Position Paper of the EuropeanSociety for Paediatric Gastroenterology, Hepatology andNutrition Committee on Nutrition. J Pediatr GastroenterolNutr. 2017;65(6):681-96.

  24. Gugliucci A, Rodríguez-Mortera R. Fructosa, un factor clavemodificable en la patogenia del síndrome metabólico, laesteatosis hepática y la obesidad. Rev Méd Urug. 2020;36(4): 418-30. Doi: 10.29193/RMU.36.4.10.

  25. Saraiva A, Carrascosa C, Ramos F, et al. Agave Syrup:Chemical Analysis and Nutritional Profile, Applications inthe Food Industry and Health Impacts. Int J Environ ResPublic Health. 2022;19(12):7022.

  26. Yamamura R, Inoue KY, Nishino K, et al. Intestinal and fecalpH in human health. Front. Microbiomes. 2023; 2:1192316.Doi: 10.3389/frmbi.2023.1192316

  27. Codex Alimentarius Commission. Standards for infant formulasand formulas for special medical purposes intendedfor infants: Codex Stan 72-1981 [Internet]. FAO/OMS; 1981[Revisado 2007, citado el 26 de mayo de 2023]. Disponibleen: https://www.fao.org/fao-who-codexalimentarius/shproxy/en/?lnk=1&url=https%253A%252F%252Fworkspace.fao.org%252Fsites%252Fcodex%252FStandards%252FCXS%2B72-1981%252FCXS_072e.pdf.

  28. Fomon AJ, Ziegler EE. Carga renal de Solutos. En: FomonSJ. Nutrición del lactante. Madrid: Mosby/Doyma libros;1995. p. 90-101.

  29. Organización mundial de la salud. Estrategia mundial dellactante y del niño pequeño. Ginebra, Suiza: Organizaciónmundial de la salud; 2003.

  30. Joint WHO/FAO/UNU Expert Consultation. Protein andamino acid requirements in human nutrition. World HealthOrgan Tech Rep Ser. 2007;(935):1-265.

  31. Paxson CL Jr, Adcock EW 3rd, Morriss FH Jr. Osmolalitiesof infant formulas. Am J Dis Child. 1977;131(2):139-41.DOI:10.1001/archpedi.1977.02120150021002.

  32. EFSA NDA Panel. Scientific Opinion on the essential compositionof infant and follow-on formulae. EFSA Journal2014;12(7):3760. Doi:10.2903/j.efsa.2014.3760

  33. Francis DK, Smith J, Saljuqi T, et al. Oral protein caloriesupplementation for children with chronic disease. CochraneDatabase Syst Rev. 2015; 2015(5):CD001914. Doi:10.1002/14651858.CD001914.pub2.

  34. Ren Q, Li K, Sun H, Zheng C, et al. The Association ofFormula Protein Content and Growth in Early Infancy:A Systematic Review and Meta-Analysis. Nutrients.2022;14(11):2255. Doi: 10.3390/nu14112255.

  35. Germán-Díaz M, Moreno-Villares JM, Dalmau-Serra J. Yahora, si es preciso aumentar el contenido en energía ynutrientes en la alimentación de un lactante, ¿qué deboemplear? Acta Pediatr Esp. 2014; 72 (9): 195-201.

  36. Lin YH, Hsu YC, Lin MC, et al . The association of macronutrientsin human milk with the growth of preterm infants.PLoS One. 2020;15(3): e0230800. Doi: 10.1371/journal.pone.0230800.

  37. Adamkin DH. Use of human milk and fortification in theNICU. J Perinatol. 2023;43(5):551-59. Doi: 10.1038/s41372-022-01532-0.

  38. Arslanoglu S, Boquien CY, King C, et al. Fortification ofHuman Milk for Preterm Infants: Update and Recommendationsof the European Milk Bank Association (EMBA)Working Group on Human Milk Fortification. Front Pediatr.2019;7: 76. Doi: 10.3389/fped.2019.00076.

  39. Hair AB, Scottoline B, Good M. Dilemmas in human milkfortification. J Perinatol. 2023;43(1):103-107. Doi: 10.1038/s41372-022-01502-6.

  40. Picaud JC, Vincent M, Buffin R. Human Milk Fortificationfor Preterm Infants: A Review. World Rev Nutr Diet. 2021;122: 225-47. Doi: 10.1159/000514744.

  41. Brown JV, Lin L, Embleton ND,et al. Multi-nutrient fortificationof human milk for preterm infants. CochraneDatabase Syst Rev. 2020 Jun 3;6(6):CD000343. Doi:10.1002/14651858.CD000343.pub3.

  42. Gu X, Shi X, Zhang L, et al. Evidence summary of humanmilk fortifier in preterm infants. Transl Pediatr.2021;10(11):3058-67. Doi: 10.21037/tp-21-476.

  43. Villalpando-Hernández S, Villalpando-Carrión S. Utilidad delos sucedáneos de la leche humana, Capítulo 3. En: MillerK, editor. Prácticas modernas de la alimentación infantil 2ªedición. México: Productos Gerber;2001. p.82.

  44. Łoś-Rycharska E, Kieraszewicz Z, Czerwionka-SzaflarskaM. Medium chain triglycerides (MCT) formulas in paediatricand allergological practice. Prz Gastroenterol.2016;11(4):226-31. Doi: 10.5114/pg.2016.61374.

  45. Valenzuela A, Nieto MS. Docosahexaenoic acid (DHA) infetal development and in infant nutrition. Rev Med Chil.2001;129(10):1203-11.

  46. Bradbury J. Docosahexaenoic acid (DHA): an ancient nutrientfor the modern human brain. Nutrients. 2011;3(5):529-54. Doi: 10.3390/nu3050529.

  47. Yang Q, Welch CD, Ayers K, et al. Early enteral fat supplementationwith microlipid and fish oil in the treatmentof two premature infants with shortbowel. Neonatology.2010;98(4):348-53. Doi:10.1159/000316067.

  48. Yang Q, Ayers K, Chen Y, et al. Early enteral fat supplementand fish oil increases fat absorption in the premature infantwith an enterostomy. J Pediatr. 2013, 163(2): 429-34. Doi:10.1016/j.jpeds.2013.01.056.

  49. Nimbkar S, Leena MM, Moses JA, et al. Medium chaintriglycerides (MCT): State-of-the-art on chemistry, synthesis,health benefits and applications in food industry.Compr Rev Food Sci Food Saf. 2022;21(2):843-67. Doi:10.1111/1541-4337.12926.

  50. Lee YY, Tang TK, Chan ES, et al. Medium chain triglycerideand medium-and long chain triglyceride: metabolism,production, health impacts and its applications-a review.Crit Rev Food Sci Nutr. 2022;62(15):4169-85. Doi:10.1080/10408398.2021.1873729.

  51. Jadhav HB, Annapure US. Triglycerides of medium-chainfatty acids: a concise review. J Food Sci Technol. 2022:1-10.Doi: 10.1007/s13197-022-05499-w.

  52. Bellini C, Ergaz Z, Radicioni M, et al. Congenital fetal andneonatal visceral chylous effusions: neonatal chylothoraxand chylous ascites revisited. A multicenter retrospectivestudy. Lymphology. 2012;45(3):91-102.

  53. Lai Y, Yu T, Qiao XY, et al. Primary intestinal lymphagiectasiadiagnosed by double-balloon enteroscopy and treated bymedium-chain triglycerides: case report. J Med Case Rep.2013; 7:19. Doi: 10.1186/1752-1947-7-19.

  54. Tessitore M, Sorrentino E, Schiano Di Cola G, et al. Malnutritionin Pediatric Chronic Cholestatic Disease: AnUp-to-Date Overview. Nutrients. 2021;13(8):2785. Doi:10.3390/nu13082785.

  55. Desai AP, Guvenc BH, Carachi R. Evidence for mediumchain triglycerides in the treatment of primary intestinallymphangiectasia. Eur J Pediatr Surg. 2009;19(4):241-5.Doi: 10.1055/s-0029-1216389.

  56. Campos-Costa F, Mateus JE, Fonseca J. Effect of mediumchaintriglycerides in chylothorax composition. PostgradMed J. 2020;96(1131):57. Doi: 10.1136/postgradmedj-2019-136878.

  57. Watanabe S, Tsujino S. Applications of Medium-ChainTriglycerides in Foods. Front Nutr. 2022; 9:802805. Doi:10.3389/fnut.2022.802805.

  58. Liu YmC, Wang HS. Medium-chain Triglyceride KetogenicDiet, An Effective Treatment for Drug-resistant Epilepsy andA Comparison with Other Ketogenic Diets. Biomed J. 2013;36:9-15. Doi: 10.4103/2319-4170.107154.

  59. Liu YM. Medium-chain triglyceride (MCT) ketogenictherapy. Epilepsia. 2008;49 Suppl 8:33-6.

  60. Merritt JL 2nd, Norris M, Kanungo S. Fatty acid oxidationdisorders. Ann Transl Med. 2018;6(24):473. Doi:10.21037/atm.2018.10.57.

  61. Van Calcar SC, Sowa M, Rohr F, et al. Nutrition managementguideline for very-long chain acyl-CoA dehydrogenasedeficiency (VLCAD): An evidence- and consensus-basedapproach. Mol Genet Metab. 2020;131(1-2):23-37. Doi:10.1016/j.ymgme.2020.10.001.

  62. Erstad BL. Osmolality and osmolarity: narrowing theterminology gap. Pharmacotherapy. 2003;23(9):1085-6.

  63. Srinivasan L, Bokiniec R, King C, et al. Increased osmolalityof breast milk with therapeutic additives. Arch Dis ChildFetal Neonatal Ed. 2004;89(6):F514-7. Doi: 10.1136/adc.2003.037192.

  64. Johnston M, Landers S, Noble L, et al. Breastfeeding andthe use of human milk. Pediatrics. 2012; 129: 827-41. Doi:10.1542/peds.2011-3552.

  65. De Abreu J, López E, Dini E. Osmolality of products andformulas for nutritional therapy. Invest Clin. 2009; 50(4):433-45.

  66. Pearson F, Johnson MJ, Leaf AA. Milk osmolality: doesit matter? Arch Dis Child Fetal Neonatal Ed. 2013;98(2):F166-9. Doi: 10.1136/adc.2011.300492.

  67. Salvia G, De Vicia B, Manguso F, et al. Effect of intragastricvolume and osmolality on mechanisms of gastroesophagealreflux in children with gastroesophageal refluxdisease. Am J Gastroenterol. 2001; 96(6):1725-32. Doi:10.1111/j.1572-0241.2001.03865.x.

  68. Ellis ZM, Tan HSG, Embleton ND, Sangild PT, van ElburgRM. Milk feed osmolality and adverse events in newborninfants and animals: a systematic review. Arch Dis ChildFetal Neonatal Ed. 2019;104(3):F333-F340. Doi: 10.1136/archdischild-2018-315946.

  69. Shaw V, McCarthy H.Nutritional assessment, dietaryrequirements, feed supplementation. En: Shaw V, editor.Clinical Paediatic Dietetics 3a edición. Oxford: BlackwellPublishing; 2007. pp. 3–20.

  70. Goulet O, Ruemmele F, Lacaille F,et al. Irreversible intestinalfailure. J Pediatr Gastroenterol Nutr. 2004;38(3):250-69.Doi: 10.1097/00005176-200403000-00006.

  71. González-Islas D, Orea-Tejeda A, Castillo-Martínez L, et al.The effects of a low-carbohydrate diet on oxygen saturationin heart failure patients: a randomized controlled clinicaltrial. Nutr Hosp. 2017;34(4):792-98. Doi: 10.20960/nh.784.




2020     |     www.medigraphic.com